DIMENSIONAL FUND ADVISORS LP - MERRIMACK PHARMACEUTICALS IN ownership

MERRIMACK PHARMACEUTICALS IN's ticker is MACK and the CUSIP is 590328209. A total of 39 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q3 2020. The put-call ratio across all filers is 1.50 and the average weighting 0.2%.

Quarter-by-quarter ownership
DIMENSIONAL FUND ADVISORS LP ownership history of MERRIMACK PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$5,533,112
-2.2%
448,752
-2.4%
0.00%0.0%
Q2 2023$5,657,508
-1.2%
459,960
-1.3%
0.00%0.0%
Q1 2023$5,728,861
+105950.7%
466,140
-1.1%
0.00%0.0%
Q4 2022$5,402
-99.7%
471,373
-0.2%
0.00%
+100.0%
Q3 2022$1,771,000
-37.6%
472,301
-0.9%
0.00%0.0%
Q2 2022$2,837,000
-7.0%
476,708
-1.2%
0.00%0.0%
Q1 2022$3,052,000
+59.7%
482,484
-1.3%
0.00%0.0%
Q4 2021$1,911,000
-20.8%
488,687
-2.1%
0.00%0.0%
Q3 2021$2,412,000
-27.1%
499,368
-3.5%
0.00%0.0%
Q2 2021$3,308,000
+1.4%
517,645
-0.3%
0.00%0.0%
Q1 2021$3,261,000
-14.0%
519,220
-5.7%
0.00%0.0%
Q4 2020$3,793,000
+67.2%
550,539
-2.9%
0.00%0.0%
Q3 2020$2,269,000
+16.0%
567,185
-3.4%
0.00%0.0%
Q2 2020$1,956,000
+41.3%
587,423
-8.8%
0.00%0.0%
Q1 2020$1,384,000
-34.7%
643,886
-4.3%
0.00%0.0%
Q4 2019$2,120,000
-29.1%
673,130
+1.0%
0.00%0.0%
Q3 2019$2,992,000
-27.3%
666,300
-2.0%
0.00%
-50.0%
Q2 2019$4,114,000
-9.5%
680,069
+4.0%
0.00%0.0%
Q1 2019$4,545,000
+106.3%
653,992
+14.6%
0.00%
+100.0%
Q4 2018$2,203,000
-27.9%
570,818
-0.5%
0.00%0.0%
Q3 2018$3,057,000
+32.9%
573,514
+22.4%
0.00%0.0%
Q2 2018$2,300,000
-22.8%
468,377
+26.6%
0.00%0.0%
Q1 2018$2,978,000
+44.3%
369,982
+83.8%
0.00%0.0%
Q4 2017$2,064,000
+448.9%
201,325
+678.8%
0.00%
Q3 2017$376,00025,8500.00%
Other shareholders
MERRIMACK PHARMACEUTICALS IN shareholders Q3 2020
NameSharesValueWeighting ↓
Western Standard LLC 1,894,013$23,353,18021.09%
Newtyn Management, LLC 1,873,694$23,102,6475.70%
Sio Capital Management, LLC 288,466$3,556,7861.10%
Madison Avenue Partners, LP 553,085$6,819,5380.97%
WITTENBERG INVESTMENT MANAGEMENT, INC. 209,739$2,5860.95%
Indaba Capital Management, L.P. 136,802$1,686,7690.50%
Sepio Capital, LP 306,680$3,781,3640.33%
Yakira Capital Management, Inc. 54,118$667,2750.18%
Centiva Capital, LP 187,803$2,315,6110.05%
FIFTH LANE CAPITAL, LP 10,929$134,4270.05%
View complete list of MERRIMACK PHARMACEUTICALS IN shareholders